NASDAQ:PRVA

Privia Health Group (PRVA) Stock Forecast, Price & News

$22.55

-0.45 (-1.96%)

(As of 10:03 AM ET)

Compare

Today's Range: $22.38
▼
$22.95
50-Day Range: $21.63
▼
$27.92
52-Week Range: $20.64
▼
$36.55

Volume: 65,549 shs
Average Volume: 1.20 million shs
Market Capitalization: $2.65 billion

P/E Ratio: 83.52
Dividend Yield: N/A
Price Target: $36.86

Privia Health Group MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 64.7% Upside
$36.86 Price Target
Short Interest: Bearish
5.86% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.88
Based on 2 Articles This Week
Insider Trading: Selling Shares
$5.23 M Sold Last Quarter
Proj. Earnings Growth: 31.82%
From $0.22 to $0.29 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.85 out of 5 stars

Medical Sector

60th out of 969 stocks

Health Services Industry

1st out of 12 stocks

3.5

Analyst's Opinion

Consensus Rating
Privia Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 10 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $36.86, Privia Health Group has a forecasted upside of 64.7% from its current price of $22.38.
Amount of Analyst Coverage
Privia Health Group has only been the subject of 2 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
5.86% of the float of Privia Health Group has been sold short.
Short Interest Ratio / Days to Cover
Privia Health Group has a short interest ratio ("days to cover") of 6.2.
Change versus previous month
Short interest in Privia Health Group has recently decreased by 4.52%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Privia Health Group does not currently pay a dividend.
Dividend Growth
Privia Health Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PRVA.

2.7

News and Social Media Coverage

News Sentiment
Privia Health Group has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Privia Health Group this week, compared to 3 articles on an average week.
Search Interest
1 people have searched for PRVA on MarketBeat in the last 30 days.
MarketBeat Follows
Only 1 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,229,950.00 in company stock.
Percentage Held by Insiders
44.80% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
92.40% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Privia Health Group are expected to grow by 31.82% in the coming year, from $0.22 to $0.29 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Privia Health Group is 82.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 108.38.
Price to Earnings Ratio vs. Sector
The P/E ratio of Privia Health Group is 82.89, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 91.36.
Price to Earnings Growth Ratio
Privia Health Group has a PEG Ratio of 2.85. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Privia Health Group has a P/B Ratio of 4.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

PRVA Price History

30 days | 90 days | 365 days | Advanced Chart

PRVA Stock News Headlines

September 24, 2023 | americanbankingnews.com

Critical Analysis: Privia Health Group (NASDAQ:PRVA) versus DocGo (NASDAQ:DCGO)

September 14, 2023 | finance.yahoo.com

Be Wary Of Privia Health Group (NASDAQ:PRVA) And Its Returns On Capital

October 2, 2023 | Edge On The Street (Ad)

Gold Could Be Heading for Record Highs - But How to Play It?

According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.

September 6, 2023 | finance.yahoo.com

Privia Health to Participate in the Morgan Stanley Healthcare Conference

August 25, 2023 | finance.yahoo.com

Privia Health Reports Results in CMS’ Medicare Shared Savings Program for the 2022 Performance Year

August 25, 2023 | finance.yahoo.com

Privia Health Reports Results in CMS’ Medicare Shared Savings Program for the 2022 Performance Year

August 19, 2023 | markets.businessinsider.com

4 Analysts Have This to Say About Privia Health Gr

August 17, 2023 | finance.yahoo.com

GEHC or PRVA: Which Is the Better Value Stock Right Now?

October 2, 2023 | Edge On The Street (Ad)

Gold Could Be Heading for Record Highs - But How to Play It?

August 16, 2023 | msn.com

Privia Health: Unit Economics Stretching Higher At Qualified Growth Rates (Rating Upgrade)

August 16, 2023 | msn.com

TD Cowen Maintains Privia Health Group (PRVA) Outperform Recommendation

August 4, 2023 | finance.yahoo.com

Is Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Price Struggling As A Result Of Its Mixed Financials?

August 3, 2023 | finance.yahoo.com

Privia Health (PRVA) Q2 Earnings and Revenues Surpass Estimates

August 3, 2023 | finance.yahoo.com

Privia Health Reports Second Quarter 2023 Financial Results

August 1, 2023 | finance.yahoo.com

Privia Health to Enter Washington State

July 31, 2023 | finance.yahoo.com

Privia Health Announces Changes to Board of Directors

July 27, 2023 | finance.yahoo.com

GEHC vs. PRVA: Which Stock Is the Better Value Option?

July 21, 2023 | markets.businessinsider.com

Privia Health Group (PRVA) Receives a Buy from RBC Capital

July 18, 2023 | markets.businessinsider.com

Privia Health Group (PRVA) Receives a Buy from Truist Financial

July 11, 2023 | finance.yahoo.com

Privia Health to Report Second Quarter 2023 Results on Thursday, August 3

June 29, 2023 | finanznachrichten.de

Privia Health Group, Inc.: Privia Health Announces Expansion of and Changes to Board of Directors

June 29, 2023 | finance.yahoo.com

Privia Health Announces Expansion of and Changes to Board of Directors

June 27, 2023 | finance.yahoo.com

Shareholders in Privia Health Group (NASDAQ:PRVA) are in the red if they invested a year ago

June 22, 2023 | markets.businessinsider.com

Privia Health Group (PRVA) Gets a Buy from Credit Suisse

May 31, 2023 | msn.com

Privia Health Group: Platform Contribution And Capitated Book Performed Strongly

May 14, 2023 | finance.yahoo.com

With 9.8% one-year returns, institutional owners may ignore Privia Health Group, Inc.'s (NASDAQ:PRVA) 9.2% stock price decline

May 11, 2023 | benzinga.com

Privia Health Gr 10% Owner Sold $536.47M In Company Stock

See More Headlines

Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Company Calendar

Last Earnings: 8/03/2023
Today: 10/02/2023
Next Earnings (Estimated): 11/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:PRVA
CUSIP: N/A
CIK: 1759655
Web: www.priviahealth.com
Phone: 571-366-8850
Fax: N/A
Employees: 964
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $36.86
High Stock Price Forecast: $43.00
Low Stock Price Forecast: $28.00
Forecasted Upside/Downside: +60.2%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.27
Trailing P/E Ratio: 85.19
Forward P/E Ratio: 104.55
P/E Growth: 2.85
Net Income: $-8,590,000.00
Net Margins: 2.26%
Pretax Margin: 1.02%
Return on Equity: 6.36%
Return on Assets: 3.98%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.82
Quick Ratio: 1.82

Sales & Book Value

Annual Sales: $1.36 billion
Price / Sales: 1.99
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.53 per share
Price / Book: 5.08

Miscellaneous

Outstanding Shares: 117,360,000
Free Float: 64,784,000
Market Cap: $2.70 billion
Optionable: Not Optionable
Beta: 0.85

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Parth Mehrotra (Age 44)
CEO & Director
Comp: $1.37M

Mr. David Mountcastle CPA (Age 52)
MBA, Exec. VP, CFO & Principal Accounting Officer
Comp: $882.07k

Mr. Thomas Bartrum (Age 56)
Exec. VP & Gen. Counsel
Comp: $608.79k

Mr. Chris Voigt
Exec. VP & Chief Technology Officer

Mr. Robert P. Borchert
Sr. VP of Investor Relations & Corp. Communications

Ms. Dana Fields CPA
Sr. VP of Internal Audit & Chief Compliance Officer

Ms. Jenny Harding
Sr. VP of People Operations

Mr. Jay Stevens
Sr. VP & Chief Growth Officer

Dr. S. Mark Cone FACOG (Age 60)
M.D., Pres of Privia Medical Group - Gulf Coast Texas

Mr. Eric J. Beyer
Exec. VP of Medical Groups

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PRVA Stock - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PRVA shares.
View PRVA analyst ratings or view top-rated stocks.
What is Privia Health Group's stock price forecast for 2023?: 10 equities research analysts have issued twelve-month price targets for Privia Health Group's stock. Their PRVA share price forecasts range from $28.00 to $43.00. On average, they predict the company's share price to reach $36.86 in the next twelve months. This suggests a possible upside of 60.2% from the stock's current price.
View analysts price targets for PRVA or view top-rated stocks among Wall Street analysts.
How have PRVA shares performed in 2023?: Privia Health Group's stock was trading at $22.71 at the beginning of the year. Since then, PRVA stock has increased by 1.3% and is now trading at $23.00.
View the best growth stocks for 2023 here.
When is Privia Health Group's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our PRVA earnings forecast.
How were Privia Health Group's earnings last quarter?: Privia Health Group, Inc. (NASDAQ:PRVA) issued its quarterly earnings data on Thursday, August, 3rd. The company reported $0.06 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.01. The firm earned $413.35 million during the quarter, compared to the consensus estimate of $392.34 million. Privia Health Group had a net margin of 2.26% and a trailing twelve-month return on equity of 6.36%.
What ETFs hold Privia Health Group's stock?: ETFs with the largest weight of Privia Health Group (NASDAQ:PRVA) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), BNY Mellon Innovators ETF (BKIV), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Fidelity Disruptive Medicine ETF (FMED), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Franklin Genomic Advancements ETF (HELX).

What guidance has Privia Health Group issued on next quarter's earnings?: Privia Health Group updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.60 billion-$1.65 billion, compared to the consensus revenue estimate of $1.61 billion.
When did Privia Health Group IPO?: (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.
What is Privia Health Group's stock symbol?: Privia Health Group trades on the NASDAQ under the ticker symbol "PRVA."
How do I buy shares of Privia Health Group?: Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Privia Health Group's stock price today?: One share of PRVA stock can currently be purchased for approximately $23.00.
How much money does Privia Health Group make?: Privia Health Group (NASDAQ:PRVA) has a market capitalization of $2.70 billion and generates $1.36 billion in revenue each year. The company earns $-8,590,000.00 in net income (profit) each year or $0.27 on an earnings per share basis.
How many employees does Privia Health Group have?: The company employs 964 workers across the globe.
How can I contact Privia Health Group?: The official website for the company is www.priviahealth.com. The company can be reached via phone at 571-366-8850 or via email at ir@priviahealth.com.

This page (NASDAQ:PRVA) was last updated on 10/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial